At issue: Management of medication noncompliance in schizophrenia by families in India

被引:32
作者
Srinivasan, TN [1 ]
Thara, R [1 ]
机构
[1] Schizophrenia Res Fdn India, Madras 600101, Tamil Nadu, India
关键词
medication compliance; involuntary treatment; outpatient; schizophrenia; India;
D O I
10.1093/oxfordjournals.schbul.a006960
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Noncompliance with medication during a symptomatic phase is a common problem in the treatment of schizophrenia patients. In India, a majority of patients live with their families and those families supervise patients' medication intake. In a study of patients attending an urban outpatient care center in India, it was noted that when the patients were acutely ill and refused to take medication, the families administered medication to them without patients' knowledge, under the supervision of the psychiatrist. This method had been practiced by families in half the cases of patient noncompliance. Many families felt that there was no other viable alternative under the circumstances. Only a minority of patients was aware of having received medication through this method, and many of them reacted negatively to it. However, the patients were subsequently taking treatment voluntarily following the reduction in the severity of the behavioral disorder with the involuntary treatment. The issues involved in this form of treatment are discussed with regard to the social and health care environment in the country.
引用
收藏
页码:531 / 535
页数:5
相关论文
共 50 条
[21]   Living with schizophrenia in India: Gender perspectives [J].
Loganathan, Santosh ;
Murthy, R. Srinivasa .
TRANSCULTURAL PSYCHIATRY, 2011, 48 (05) :569-584
[22]   Heredity of Schizophrenia in India: A 1928 debate [J].
Haldipur, C. V. .
ASIAN JOURNAL OF PSYCHIATRY, 2023, 88
[23]   The Family Support Movement and Schizophrenia in India [J].
Kalyanasundaram Seshadri ;
Thanapal Sivakumar ;
Aarti Jagannathan .
Current Psychiatry Reports, 2019, 21
[24]   The Family Support Movement and Schizophrenia in India [J].
Seshadri, Kalyanasundaram ;
Sivakumar, Thanapal ;
Jagannathan, Aarti .
CURRENT PSYCHIATRY REPORTS, 2019, 21 (10)
[25]   The issue of mortality in schizophrenia [J].
Corruble, Emmanuelle .
THERAPIE, 2008, 63 (03) :247-250
[26]   Mediating Effect Of The Motivation For Medication Use On Disease Management And Medication Adherence Among Community-Dwelling Patients With Schizophrenia [J].
Hsieh, Wen Ling ;
Lee, Shih Kai ;
Chien, Wai Tong ;
Liu, Wen, I ;
Lai, Chien Yu ;
Liu, Chieh Yu .
PATIENT PREFERENCE AND ADHERENCE, 2019, 13 :1877-1887
[27]   Antipsychotic medication in schizophrenia: a review [J].
Lally, John ;
MacCabe, James H. .
BRITISH MEDICAL BULLETIN, 2015, 114 (01) :169-179
[28]   Pharmacist-led Si-care (schizophrenia care) model to improve medication adherence and symptom management in schizophrenia [J].
Cahaya, Noor ;
Kristina, Susi Ari ;
Widayanti, Anna Wahyuni ;
Green, James A. .
EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2024, 16
[29]   WHAT DO LARGE SCALE STUDIES OF MEDICATION IN SCHIZOPHRENIA ADD TO OUR MANAGEMENT STRATEGIES? [J].
Agius, Mark ;
Davis, Abigail ;
Gilhooley, Michael ;
Chapman, Shelley ;
Zaman, Rashid .
PSYCHIATRIA DANUBINA, 2010, 22 (02) :323-328
[30]   Schizophrenia construct: Quandaries and conundrums in India and LAMIC [J].
Rangaswamy, Thara ;
Arunachaleeswaran, Pavithra ;
Raghavan, Vijaya ;
John, Sujit .
SCHIZOPHRENIA RESEARCH, 2022, 242 :118-120